Medical devices, healthcare technology and the business of care
PMA approval · P160025

ASTRON PULSAR STENT SYSTEM, PULSAR-18 STENT SYSTEM

Biotronik AG · Decision date Mar 23, 2017

MEDTECHLEDGER EXPLANATIONP160025

What did the FDA approve?

FDA approved PMA P160025 for the Astron Pulsar Stent System and Pulsar-18 Stent System on March 23, 2017. The applicant is Biotronik AG, and the product code is NIP under the specialty Cardiovascular.

The stated indication is improving luminal diameter in patients with symptomatic de novo, restenotic or occlusive lesions in the superficial femoral or proximal popliteal arteries, with reference vessel diameters from 3.0 to 6.0mm and total lesion lengths up to 190mm. The source statement reports an intended purpose, not independent proof of safety or clinical effectiveness.

FDA approval order statement

Approval for the Astron Pulsar Stent System and Pulsar-18 Stent System. These devices are indicated for use to improve luminal diameter in patients with symptomatic de novo, restenotic or occlusive lesions located in the superficial femoral or proximal popliteal arteries, with reference vessel diameters from 3.0 to 6.0mm and total lesion lengths up to 190mm.
Regulatory pathway
Original PMA
Clinical specialty
Cardiovascular
Decision date
Mar 23, 2017

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P160025
Regulatory pathway
Premarket approval application
Applicant
Biotronik AG
Product code
NIP
Decision code
APPR
Decision date
Mar 23, 2017
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: STENT, SUPERFICIAL FEMORAL ARTERY.

Applicant
Biotronik AG
Product code
NIP
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P160025 received

    Application receipt date recorded by FDA.

  2. P160025 · FDA decision

    APPR

  3. P160025/S026 · Related supplement

    Pulsar-18 T3 Peripheral Self-Expanding Nitinol Stent System

Timeline entries are records held by MedtechLedger for P160025. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160025

Product / regulatory recordCompanyPathwayDecision dateSource
Biotronik AGPMA supplementSep 11, 2026FDA

Explore the linked device profile

Other records with product code NIP

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik AG

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Ackerstrasse 6, Bülach, 8180

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records